Aufenacker Theo J, van Geldere Dirk, van Mesdag Taco, Bossers Astrid N, Dekker Benno, Scheijde Edo, van Nieuwenhuizen Roos, Hiemstra Esther, Maduro John H, Juttmann Jan-Willem, Hofstede Diederik, van Der Linden Cunera T M, Gouma Dirk J, Simons Maarten P
Department of Surgery, Onze Lieve Vrouwe Gasthuis, Eerste Oosterparkstraat 279, 1091 HA Amsterdam, The Netherlands.
Ann Surg. 2004 Dec;240(6):955-60; discussion 960-1. doi: 10.1097/01.sla.0000145926.74300.42.
To determine whether the use of prophylactic antibiotics is effective in the prevention of postoperative wound infection after Lichtenstein open mesh inguinal hernia repair.
A recent Cochrane meta-analysis (2003) concluded that "antibiotic prophylaxis for elective inguinal hernia repair cannot be firmly recommended or discarded."
Patients with a primary inguinal hernia scheduled for Lichtenstein repair were randomized to a preoperative single dose of 1.5 g intravenous cephalosporin or a placebo. Patients with recurrent hernias, immunosuppressive diseases, or allergies for the given antibiotic were excluded. Infection was defined using the Centers for Disease Control and Prevention criteria.
We included 1040 patients in the study between November 1998 and May 2003. According to the intention-to-treat principle, 1008 patients were analyzed. There were 8 infections (1.6%) in the antibiotic prophylaxis group and 9 (1.8%) in the placebo group (P = 0.82). There was 1 deep infection in the antibiotic prophylaxis group and 2 in the placebo group (P = 0.57). Statistical analysis showed an absolute risk reduction of 0.19% (95% confidence interval, -1.78%-1.40%) and a number needed to treat of 520 for the total number of infections. For deep infection, the absolute risk reduction is 0.20% (95% confidence interval, -0.87%-0.48%) with a number needed to treat of 508.
A low percentage (1.7%) of wound infection after Lichtenstein open mesh inguinal (primary) hernia repair was found, and there was no difference between the antibiotic prophylaxis or placebo group. The results show that, in Lichtenstein inguinal primary hernia repair, antibiotic prophylaxis is not indicated in low-risk patients.
确定预防性使用抗生素在预防Lichtenstein开放式无张力腹股沟疝修补术后伤口感染方面是否有效。
最近一项Cochrane荟萃分析(2003年)得出结论,“对于择期腹股沟疝修补术,不能明确推荐或摒弃预防性使用抗生素”。
计划接受Lichtenstein修补术的原发性腹股沟疝患者被随机分为术前静脉注射1.5 g头孢菌素单剂量组或安慰剂组。复发性疝、免疫抑制性疾病或对特定抗生素过敏的患者被排除。根据疾病控制与预防中心的标准定义感染情况。
1998年11月至2003年5月期间,我们将1040例患者纳入研究。根据意向性分析原则,对1008例患者进行了分析。抗生素预防组有8例感染(1.6%),安慰剂组有9例感染(1.8%)(P = 0.82)。抗生素预防组有1例深部感染,安慰剂组有2例深部感染(P = 0.57)。统计分析显示,总体感染的绝对风险降低率为0.19%(95%置信区间,-1.78%至1.40%),需治疗人数为520。对于深部感染,绝对风险降低率为0.20%(95%置信区间,-0.87%至0.48%),需治疗人数为508。
发现Lichtenstein开放式无张力腹股沟(原发性)疝修补术后伤口感染率较低(1.7%),抗生素预防组与安慰剂组之间无差异。结果表明,在Lichtenstein腹股沟原发性疝修补术中,低风险患者无需预防性使用抗生素。